Ultrasound-Guided Serratus Plane Block Vs Paravertebral Block For Chronic Post-mastectomy Pain.

NCT04317898 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-07-15

No results posted yet for this study

Summary

compare the analgesic efficacy between ultrasound paraverbral block and serratus block in post mastectomy pain.

Conditions

  • Post-mastectomy Pain Syndrome

Interventions

PROCEDURE

serratus plane block by ultra-sound

To perform Serratus block, patients will be placed in the lateral decubitus position with the affected side facing up, or in the prone position with the affected side facing the operator . After sterile preparation, a linear ultrasound probe will be utilized to identify the latissimusdorsi and serratus anterior muscles in a sagittal plane. The plane superficial to the serratus anterior muscle and below the latissimusdorsi muscle will be identified. The skin will be topicalized with 1 mL of 1% lidocaine using a 30-gauge needle. Using an in-plane approach, a 25-gauge 1.5-cm needle will be used to inject a total of 20-mL of 0.25% bupivacaine with 80 mg of triamcinlone under direct ultrasound visualization.

PROCEDURE

paravertebral block by ultra-sound

TPVB will be given using high frequency linear US transducer, place the probe parallel to the vertebral spine at T2 level and shifted 2-3 cm laterally to obtain the appropriate visualization. Following the identification of plura, transverse process and paravertebral space, the needle will be inserted in caudocranial direction using in-plane approach. Confirm negative vessel or pleural breach via aspiration then proceed with local anaesthetic 10ml of 0.25% bubivacine and 80mg triamcinlone slowly; the pleura will be seen to be pushed downward.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mohammed Mohammed Abd El-Latif, Prof of Anesthesia · Mohammed MohammedAbd El-Latif

  • Ashraf Amin Mohammed, Prof of Anesthesia · Ashraf Amin Mohammed

  • Rania Mohammed Abd El-Emam, Lecturer of Anesthesia · Rania Mohammed Abd El-Emam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2021-04-30
Completion
2021-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04317898 on ClinicalTrials.gov